TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities
Kun‐Hua Tu, Pei-Yi Fan, Tai‐Di Chen, Wen‐Yu Chuang, Chao‐Yi Wu, Cheng‐Lung Ku, Ya-Chung Tian, Chih-Wei Yang 等 10 位
Chang Gung Memorial Hospital Taoyuan Chang Gung Memorial Hospital Linkou Chang Gung Memorial Hospital Chang Gung University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
TAFRO syndrome is an extremely rare form of idiopathic MCD, characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis on bone marrow biopsy, and organomegaly. Like idiopathic MCD, renal involvement is also a common presentation in patients with TAFRO syndrome. Furthermore, membranoproliferative glomerulonephritis (MPGN)-like injury and thrombotic microangiopathy (TMA) are the most reported histopathologic findings of renal biopsy. Several molecular mechanisms have been previously postulated in order to explain the TAFRO syndrome symptoms, including abnormal production of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), etc. The role of these cytokines in renal injury, however, is not well understood. The aim of this review article is to summarize the latest knowledge of molecular mechanisms behind the TAFRO syndrome and their potential role in renal damage.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学IgG4-Related and Inflammatory Diseases
Renal Diseases and Glomerulopathies · Vasculitis and related conditions